Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 USD | -0.92% |
|
-0.31% | -45.61% |
04-04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
01-08 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
- Stock Market
- Equities
- MURA Stock
- News Mural Oncology plc
- Analyst Reco.